Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pruritus, Rash
Clinical narrative: some numbness; Swollen lymph nodes in left underarm and neck; fatigue; stuffiness; Cold like symptoms; Medicine Taste in mouth following both doses; Rashes and itchiness following 2nd dose; Rashes and itchiness following 2nd dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Aug2021 09:00 (Lot number: FA7485) at the age of 39 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known Allergies: Onion" (unspecified if ongoing), notes: Known Allergies: Onion; "Factor 5 lyden" (unspecified if ongoing); "Graves' disease" (unspecified if ongoing); "Hashimotos' Disease" (unspecified if ongoing); "Arthritis" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Chronic Polyp Disease" (unspecified if ongoing); "Hypertrophy Nerve Sensitivity" (unspecified if ongoing); "SVT" (unspecified if ongoing); "Allergic to cipro" (unspecified if ongoing); "known allergies: IV catheter dye" (unspecified if ongoing). Concomitant medication(s) included: ALPRAZOLAM. Past drug history included: Cyclobenzaprine, reaction(s): "known allergies: Cyclobenzaprine". Vaccination history included: Bnt162b2 (product: COVID 19, brand: Pfizer, lot number: FA7484, lot unknown: False, administration time: 11:15 AM, dose number: 1, vaccine location: Left arm), administration date: 09Aug2021, when the patient was 39 years old, for COVID-19 immunization, reaction(s): "Immediate tremor in bottom lips", "Swollen lymph node in neck", "Rashes", "itching", "some numbness". The following information was reported: HYPOAESTHESIA (non-serious) with onset 31Aug2021, outcome "recovering", described as "some numbness"; LYMPHADENOPATHY (non-serious) with onset 31Aug2021, outcome "recovering", described as "Swollen lymph nodes in left underarm and neck"; FATIGUE (non-serious) with onset 31Aug2021, outcome "recovering", described as "fatigue"; NASAL CONGESTION (non-serious) with onset 31Aug2021, outcome "recovering", described as "stuffiness"; NASOPHARYNGITIS (non-serious) with onset 31Aug2021, outcome "recovering", described as "Cold like symptoms "; DYSGEUSIA (non-serious) with onset 31Aug2021, outcome "recovering", described as "Medicine Taste in mouth following both doses"; RASH (non-serious), PRURITUS (non-serious) all with onset 31Aug2021, outcome "recovering" and all described as "Rashes and itchiness following 2nd dose". Therapeutic measures were not taken as a result of hypoaesthesia, lymphadenopathy, fatigue, nasal congestion, nasopharyngitis, dysgeusia, rash, pruritus.  Additional information: Age group reported as Adult (18-64 Years). Patient was not pregnant at the time of vaccination. Patient did not receive any other vaccine in four weeks. Other medications in two weeks included Alprazolam. It was reported that Ae resulted in None of the above. If covid prior vaccination and If covid tested post vaccination was reported as No. Adverse event: Adverse event: Immediate tremor in bottom lips following 1st dose Swollen lymph node in neck following 1st dose Rashes and itching following 1st dose and some numbness Swollen lymph nodes in left underarm and neck following 2nd dose Cold like symptoms (fatigue, stuffiness) following 2nd dose Rashes and itchiness following 2nd dose Medicine Taste in mouth following both doses.  No follow-up attempts are possible. No further information is expected.